NYSE:DOCS Doximity (DOCS) Stock Price, News & Analysis $29.64 -1.03 (-3.37%) Closing price 03:59 PM EasternExtended Trading$29.62 -0.02 (-0.06%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Doximity Stock (NYSE:DOCS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Doximity alerts:Sign Up Key Stats Today's Range$29.42▼$31.1350-Day Range$24.80▼$34.6452-Week Range$17.15▼$51.85Volume1.27 million shsAverage Volume3.82 million shsMarket Capitalization$5.29 billionP/E Ratio41.16Dividend YieldN/APrice Target$30.59Consensus RatingHold Company Overview Doximity, Inc. operates a digital platform designed for medical professionals, including physicians and other clinicians. Its services support professional networking, medical news and research discovery, career development, and communication among healthcare professionals. The company also offers clinical workflow tools, including Doximity Dialer, which enables clinicians to make calls and conduct video visits using a work number, as well as digital fax and document services. Doximity provides marketing and recruitment solutions to healthcare organizations and life sciences companies. Founded in 2010, Doximity primarily serves the U.S. healthcare market. The company was co-founded by Jeff Tangney, who serves as its chief executive officer.AI Generated. May Contain Errors. Read More Doximity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks57th Percentile Overall ScoreDOCS MarketRank™: 2.868438991135 of 5 starsDoximity scored higher than 57% of companies evaluated by MarketBeat, and ranked 993rd out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingDoximity has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 8 buy ratings, 14 hold ratings, and 3 sell ratings.Upside/DownsideThe consensus price target for Doximity is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageDoximity has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Doximity's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth23.61% Earnings GrowthEarnings for Doximity are expected to grow by 23.61% in the coming year, from $0.72 to $0.89 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 41.82, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.78.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 41.82, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.98.Price to Earnings Growth RatioDoximity has a PEG Ratio of 33.31. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 5.78. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.71% of the float of Doximity has been sold short.Short Interest Ratio / Days to CoverDoximity has a short interest ratio ("days to cover") of 2.68, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Doximity has recently decreased by 23.54%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.19 News SentimentDoximity has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.37 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Doximity this week, compared to 8 articles on an average week.Search Interest6 people have searched for DOCS on MarketBeat in the last 30 days. This is an increase of 20% compared to the previous 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $801,442.00 in company stock.Percentage Held by Insiders31.80% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Doximity's insider trading history. Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DOCS Stock News HeadlinesInsider Selling: Doximity (NYSE:DOCS) CAO Sells $84,041.13 in StockNovember 18 at 5:52 AM | insidertrades.comDoximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCSNovember 16 at 7:30 PM | prnewswire.comTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.November 19 at 1:00 AM | Base Camp Trading (Ad)DOCS expands clinical AI tools across three major US health systemsNovember 16 at 2:33 PM | msn.comBronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor HarmNovember 16 at 1:00 PM | globenewswire.comDEADLINE ALERT for Doximity, Inc. (DOCS), Better Home & Finance Holding Company (BETR), Honeywell Aerospace, Inc. (HONA) and Tigo Energy, Inc. (TYGO): The Law Offices of Frank R. Cruz Reminds Investors of Lead Plaintiff Deadlines in Securities Fraud Class ActionsNovember 16 at 9:29 AM | globenewswire.comDoximity (NYSE:DOCS) Stock: Insider Timothy Cabral Sells 10,721 SharesNovember 10, 2026 | insidertrades.comDoximity (NYSE:DOCS) Stock: Insider Kira Scherer Wampler Sells 2,000 SharesNovember 5, 2026 | insidertrades.comSee More Headlines DOCS Stock Analysis - Frequently Asked Questions How have DOCS shares performed this year? Doximity's stock was trading at $44.26 at the beginning of 2026. Since then, DOCS shares have decreased by 32.1% and is now trading at $30.0590. How were Doximity's earnings last quarter? Doximity, Inc. (NYSE:DOCS) released its earnings results on Thursday, November, 5th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.17. The company's revenue was up 3.6% compared to the same quarter last year. Read the conference call transcript. How will Doximity's stock buyback program work? Doximity's board authorized a stock buyback plan on Thursday, February 5th 2026, which authorizes the company to buy back $500 million in outstanding shares, according to EventVestor. This means that the company could purchase up to 8% of its stock through open market purchases. Stock buyback plans are usually an indication that the company's leadership believes its stock is undervalued. When did Doximity IPO? Doximity (DOCS) raised $501 million in an IPO on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities acted as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. Who are Doximity's major shareholders? Doximity's top institutional investors include State Street Corp (2.32%), Assenagon Asset Management S.A. (0.57%), Algert Global LLC (0.56%) and Goldman Sachs Group Inc. (0.47%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Siddharth Sitaram, Kira Scherer Wampler, Watkin Phoebe L Yang, Regina M Benjamin and Timothy S Cabral. View institutional ownership trends. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Doximity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Doximity investors own include NVIDIA (NVDA), CrowdStrike (CRWD), Advanced Micro Devices (AMD), Tesla (TSLA), Palantir Technologies (PLTR), PayPal (PYPL) and Walt Disney (DIS). Company Calendar Last Earnings11/05/2026Today11/19/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 DOCS's financial health is in the Green zone, according to TradeSmith. DOCS has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNYSE:DOCS Previous SymbolNASDAQ:DOCS CIK1516513 Webdoximity.com Phone(650) 549-4330FaxN/AEmployees880Year Founded2010Price Target and Rating Average Price Target for Doximity$30.59 High Price Target$50.00 Low Price Target$18.00 Potential Upside/Downside+3.3%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage25 Analysts Profitability EPS (Trailing Twelve Months)$0.72 Trailing P/E Ratio41.00 Forward P/E Ratio33.29 P/E Growth33.31Net Income$196.05 million Net Margins21.12% Pretax Margin30.78% Return on Equity15.80% Return on Assets13.38% Debt Debt-to-Equity RatioN/A Current Ratio6.37 Quick Ratio6.37 Sales & Book Value Annual Sales$644.86 million Price / Sales8.20 Cash Flow$1.18 per share Price / Cash Flow25.10 Book Value$5.20 per share Price / Book5.70Miscellaneous Outstanding Shares178,410,000Free Float121,675,000Market Cap$5.29 billion OptionableOptionable Beta1.29 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NYSE:DOCS) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersChase, Wells Fargo and Capital One all showed errors on Nov. 16On November 16, customers of Chase, Bank of America, Wells Fargo, Capital One and Zelle reported errors when t...Cedar Gold Group | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredUnder 3 cents a nightBill Poulos's Black Friday deal: a full year of the Instant Scanner for $7, one payment. The regular price is ...Profits Run | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Doximity With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.